S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
Has the Fed lost control of the banking system? (Ad)
Roku stock and the mother of all entry opportunities
AI powerhouse NVIDIA will hit $1000 soon
Laser breakthrough could send stock soaring 2,467% (Ad)
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
Rivian shares gets discounted; shares can move lower 
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
The Trade Desk: 3 reasons to buy before a new all-time high
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard
S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
Has the Fed lost control of the banking system? (Ad)
Roku stock and the mother of all entry opportunities
AI powerhouse NVIDIA will hit $1000 soon
Laser breakthrough could send stock soaring 2,467% (Ad)
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
Rivian shares gets discounted; shares can move lower 
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
The Trade Desk: 3 reasons to buy before a new all-time high
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard
S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
Has the Fed lost control of the banking system? (Ad)
Roku stock and the mother of all entry opportunities
AI powerhouse NVIDIA will hit $1000 soon
Laser breakthrough could send stock soaring 2,467% (Ad)
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
Rivian shares gets discounted; shares can move lower 
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
The Trade Desk: 3 reasons to buy before a new all-time high
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard
S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
Has the Fed lost control of the banking system? (Ad)
Roku stock and the mother of all entry opportunities
AI powerhouse NVIDIA will hit $1000 soon
Laser breakthrough could send stock soaring 2,467% (Ad)
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
Rivian shares gets discounted; shares can move lower 
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
The Trade Desk: 3 reasons to buy before a new all-time high
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard
OTCMKTS:EBOSF

EBOS Group (EBOSF) Stock Price, News & Analysis

$28.25
0.00 (0.00%)
(As of 05/12/2023)
Today's Range
$28.25
$28.25
50-Day Range
$28.25
$28.25
52-Week Range
$28.00
$28.25
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About EBOS Group

EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, New Zealand, and Southeast Asia. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and health communications, programs, and consultancy services. It also offers community based health care services and programs; vitamins, minerals and supplements, herbal and fruit teas, and natural toothpastes, as well as functional foods, including molasses and manuka honey; Pharmacy Choice, a five step integrated retail program for independent pharmacies; and healthSAVE, a community pharmacy banner that helps members drive their retail businesses. In addition, the company supplies health and wellness products to public and private hospitals, day surgeries, general practice, aged care facilities, specialist clinics, government, and non-profit health agencies, as well as clinically essential products; and provides pharmacy services to private and public hospitals, cancer centers, correctional facilities, and veterinary clinics. Further, it offers allografts solutions; healthcare distribution, warehousing, clinical trial management, and product registration services; clinical trial logistics; aesthetic healthcare devices, medical-grade cosmeceuticals, and injectables; and surgical devices and medical consumables. Additionally, the company provides pet nutrition, treats, clean-up, and grooming products and accessories; and wholesales veterinary products for companion animals, production animals, and equine athletes. The company was formerly known as Early Bros Dental & Surgical Supplies Ltd. and changed its name to EBOS Group Limited in 1986. EBOS Group Limited was incorporated in 1922 and is headquartered in Docklands, Australia.

EBOSF Stock Price History

EBOSF Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com
Receive EBOSF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for EBOS Group and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Distribution
Sub-Industry
N/A
Current Symbol
OTCMKTS:EBOSF
CIK
N/A
Fax
N/A
Employees
5,000
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Key Executives

  • Mr. John Cullity
    Chief Executive Officer
  • Mr. Leonard Hansen
    CFO & Chief Accountant
  • Mithran Naiker
    Chief Information Officer
  • Ms. Janelle Cain
    General Counsel
  • Ms. Jacinta McCarthy
    Group General Manager of Human Resources
  • Mr. Simon Bunde
    Executive General Manager of Strategic Operations, ESG & Innovation
  • Ms. Julie Dillon
    Chief Executive Officer of Animal Care
  • Mr. Matthew Muscio
    Chief Executive Officer of Medical Technology
  • Mr. Brett Barons
    Chief Executive Officer of Symbion














EBOSF Stock Analysis - Frequently Asked Questions

Should I buy or sell EBOS Group stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for EBOS Group in the last twelve months. There are currently 1 sell rating for the stock. The consensus among Wall Street equities research analysts is that investors should "sell" EBOSF shares.
View EBOSF analyst ratings
or view top-rated stocks.

How have EBOSF shares performed in 2024?

EBOS Group's stock was trading at $28.25 on January 1st, 2024. Since then, EBOSF stock has increased by 0.0% and is now trading at $28.25.
View the best growth stocks for 2024 here
.

Are investors shorting EBOS Group?

EBOS Group saw a increase in short interest in January. As of January 15th, there was short interest totaling 251,000 shares, an increase of 11.0% from the December 31st total of 226,100 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is presently ∞ days.
View EBOS Group's Short Interest
.

How do I buy shares of EBOS Group?

Shares of EBOSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:EBOSF) was last updated on 2/23/2024 by MarketBeat.com Staff